NEK9 (NIMA Related Kinase 9): A Key Mitotic Regulator and Emerging Cancer Biomarker

Explore the genomic architecture, expression patterns, disease associations, and mutational landscape of NEK9, a serine/threonine kinase essential for mitotic spindle formation and cytokinesis.

Gene Information Card

Symbol NEK9
Full Name NIMA related kinase 9
Gene Type protein coding
Chromosomal Location 14q24.3
NCBI Gene ID 91754 ncbi.nlm.nih.gov/gene/91754
Ensembl ID ENSG00000119638
UniProt ID Q8TD19
OMIM ID 609798
HGNC ID 18591
Aliases Nercc1, NEK8, Nek9, NERCC1

Description

NEK9 (NIMA related kinase 9) encodes a serine/threonine kinase belonging to the NIMA (never in mitosis A) family. It plays a critical role in mitotic progression, particularly in centrosome separation, spindle formation, and cytokinesis. NEK9 is activated during mitosis and phosphorylates downstream targets such as NEK6 and NEK7. It is widely expressed and has been implicated in various cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Nephronophthisis-like phenotype NEK9 mutations impair ciliary function and mitotic progression, leading to renal cystic disease. ClinVar, OMIM
Cancer (multiple types) Overexpression or mutations in NEK9 promote tumorigenesis via dysregulated mitosis and genomic instability. COSMIC, PubMed
Primary microcephaly Biallelic loss-of-function mutations in NEK9 cause microcephaly due to defective neurogenesis. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 25.4 High
Bone marrow 18.2 Medium
Lymph node 15.6 Medium
Brain 12.3 Medium
Liver 8.7 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 20.5 Cervical carcinoma; high expression
K562 15.2 Chronic myelogenous leukemia
A549 12.8 Lung carcinoma
MCF7 10.1 Breast adenocarcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1646A>G (p.Asn549Ser) Missense Rare Potential gain-of-function; associated with cancer
c.2140C>T (p.Arg714Trp) Missense Rare Loss-of-function; linked to microcephaly
c.1450_1451del (p.Leu484fs) Frameshift Very rare Loss-of-function; causes truncated protein
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in NEK9 impair kinase activity, leading to mitotic defects and ciliary dysfunction, as seen in microcephaly and nephronophthisis.

Gain of Function (GOF)

Gain-of-function mutations may enhance kinase activity, promoting uncontrolled cell proliferation and tumorigenesis, though specific variants are not yet fully characterized.

Dominant Negative (DN)

Dominant-negative effects have been suggested for some missense mutations that disrupt protein interactions, but evidence is limited.

Gene Ontology (GO)

• protein serine/threonine kinase activity • ATP binding
• centrosome • mitotic spindle
• cell division • cytokinesis
• cilium assembly • protein phosphorylation

Pathways

Mitotic G2-G2/M phases
Cell Cycle
Regulation of PLK1 Activity at G2/M Transition
Centrosome maturation

Protein Summary

NEK9 is a 979-amino-acid protein with an N-terminal kinase domain and a C-terminal regulatory domain containing RCC1-like repeats. It is auto-phosphorylated during mitosis and activates NEK6/NEK7. NEK9 localizes to centrosomes and the mitotic spindle, regulating microtubule dynamics. It also interacts with the BBSome complex, linking it to ciliary function.

Related Products

Product name Cat.No. Species Gene ID
NEK9 Knockout HEK293 Cell Line EDJ-KQ10777 Human 91754 Details Get a Quote
NEK9 Knockout A-549 Cell Line EDJ-KQ38397 Human 91754 Details Get a Quote
NEK9 Knockout HCT 116 Cell Line EDJ-KQ38398 Human 91754 Details Get a Quote
NEK9 Knockout HeLa Cell Line EDJ-KQ38399 Human 91754 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: